We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synpromics and GE Healthcare Unite

News   Jan 04, 2017 | Original Story From Synpromics, UK

 
Synpromics and GE Healthcare Unite
 
 
 

RELATED ARTICLES

Mouse Model Shows Gene Therapy Vectors Carrying Telomerase Gene Do Not Increase Cancer Risk

News

Gene therapy with telomerase was developed in 2012 and has proved effective in mice against infarction, as well as in mouse models of aplastic anaemia and idiopathic pulmonary fibrosis associated to short telomeres.

READ MORE

Sprouty 1 and Sprouty 2 Offer Potential to Combat Cancer

News

Two molecules, Sprouty 1 and Sprouty 2, modify the survival of effector T cells and the development of memory CD8 T cells. These findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE